Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CodeBreaK 105
NCT04380753Phase 1Completed
- Sponsor
- Amgen
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of sotorasib in solid tumor, sponsored by Amgen. Primary endpoints: Dose-limiting Toxicities, Treatment-emergent Adverse Events and 3 more. Started Apr 2020; status: completed.
02
Drugs
sotorasib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04380753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04380753.